Ringoes, NJ, United States of America

Deborah Sokol Ricci

This inventor holds 1 USPTO granted patent and 2 EPO patents. Top assignee: Janssen Pharmaceutica Nv. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Deborah Sokol Ricci. Retrieved from https://idiyas.com/inventor/deborah-sokol-ricci

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Deborah Sokol Ricci

Introduction

Deborah Sokol Ricci is a prominent inventor based in Ringoes, NJ (US). She has made significant contributions to the field of medical research, particularly in the area of cancer treatment. Her work focuses on improving patient outcomes through innovative methods and technologies.

Latest Patents

Deborah holds a patent for "Biological markers for identifying patients for treatment with abiraterone acetate." This patent outlines methods for predicting the likelihood of survival following treatment with abiraterone acetate and prednisone in patients diagnosed with castration-resistant prostate cancer (CRPC). This innovation is crucial for personalizing treatment plans and enhancing patient care.

Career Highlights

Deborah has had a successful career at Janssen Pharmaceutica NV, where she has been involved in groundbreaking research and development. Her expertise in the pharmaceutical industry has allowed her to contribute to advancements in cancer therapies and patient management.

Collaborations

Throughout her career, Deborah has collaborated with esteemed colleagues, including Weimin Li and Michael Gormley. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Deborah Sokol Ricci's work exemplifies the impact of innovation in the medical field. Her contributions to cancer treatment through her patented methods highlight the importance of research and collaboration in improving patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…